M. Ozalevli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
M. Ozalevli has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Hakki Unlugenc
Cukurova University, Faculty of Medicine, Department of Anaesthesiology, Adana, Turkey
6 shared publications T. Güler
3 shared publicationsG. Isik
2 shared publicationsG. Işik
2 shared publicationsS. Gunasti
2 shared publicationsS. Olguner
2 shared publications
Latest Publications
- 1 June 2006
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 23 (Supplement) , 17
A comparative study on the safety and effectiveness of remifentanil and small-dose ketamine during minor surgical procedures under local anaesthesia
- 1 June 2006
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 23 (Supplement) , 17
A comparative study on the safety and effectiveness of remifentanil and small-dose ketamine during minor surgical procedures under local anaesthesia
- 1 June 2006
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 23 (Supplement) , 114
Double-blind comparison of spinal block with three lidocainemorphine mixture in knee arthroplasty
- 1 June 2006
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 23 (Supplement) , 114
Double-blind comparison of spinal block with three lidocainemorphine mixture in knee arthroplasty
- 15 August 2005
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 49 (10) , 1514-1519
The effect of adding intrathecal magnesium sulphate to bupivacaine–fentanyl spinal anaesthesia
Background: The addition of intrathecal (IT) magnesium to spinal fentanyl prolongs the duration of spinal analgesia for vaginal delivery. In this prospective, randomized, double‐blind, controlled study, we investigated the effect of adding IT magnesium sulphate to bupivacaine–fentanyl spinal anaesthesia.Methods: One hundred and two ASA I or II adult patients undergoing lower extremity surgery were recruited. They were randomly allocated to receive 1.0 ml of preservative‐free 0.9% sodium chloride (group S) or 50 mg of magnesium sulphate 5% (1.0 ml) (group M) following 10 mg of bupivacaine 0.5% plus 25 µg of fentanyl intrathecally. We recorded the following: onset and duration of sensory block, the highest level of sensory block, the time to reach the highest dermatomal level of sensory block and to complete motor block recovery and the duration of spinal anaesthesia.Results: Magnesium caused a delay in the onset of both sensory and motor blockade. The highest level of sensory block was significantly lower in group M than in group S at 5, 10 and 15 min (P < 0.001). The median time to reach the highest dermatomal level of sensory block was 17 min in group M and 13 min in group S (P < 0.05). The mean degree of motor block was also lower in group M at 5, 10 and 15 min (P < 0.001). The median duration of spinal anaesthesia was longer in group M (P < 0.001).Conclusion: In patients undergoing lower extremity surgery, the addition of IT magnesium sulphate (50 mg) to spinal anaesthesia induced by bupivacaine and fentanyl significantly delayed the onset of both sensory and motor blockade, but also prolonged the period of anaesthesia without additional side‐effects.
- 15 August 2005
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 49 (10) , 1514-1519
The effect of adding intrathecal magnesium sulphate to bupivacaine–fentanyl spinal anaesthesia
Background: The addition of intrathecal (IT) magnesium to spinal fentanyl prolongs the duration of spinal analgesia for vaginal delivery. In this prospective, randomized, double‐blind, controlled study, we investigated the effect of adding IT magnesium sulphate to bupivacaine–fentanyl spinal anaesthesia.Methods: One hundred and two ASA I or II adult patients undergoing lower extremity surgery were recruited. They were randomly allocated to receive 1.0 ml of preservative‐free 0.9% sodium chloride (group S) or 50 mg of magnesium sulphate 5% (1.0 ml) (group M) following 10 mg of bupivacaine 0.5% plus 25 µg of fentanyl intrathecally. We recorded the following: onset and duration of sensory block, the highest level of sensory block, the time to reach the highest dermatomal level of sensory block and to complete motor block recovery and the duration of spinal anaesthesia.Results: Magnesium caused a delay in the onset of both sensory and motor blockade. The highest level of sensory block was significantly lower in group M than in group S at 5, 10 and 15 min (P < 0.001). The median time to reach the highest dermatomal level of sensory block was 17 min in group M and 13 min in group S (P < 0.05). The mean degree of motor block was also lower in group M at 5, 10 and 15 min (P < 0.001). The median duration of spinal anaesthesia was longer in group M (P < 0.001).Conclusion: In patients undergoing lower extremity surgery, the addition of IT magnesium sulphate (50 mg) to spinal anaesthesia induced by bupivacaine and fentanyl significantly delayed the onset of both sensory and motor blockade, but also prolonged the period of anaesthesia without additional side‐effects.
- 1 May 2005
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 22 (Supplement) , 102
Intrathecal S(+) ketamine, fentanyl, or placebo combined with bupivacaine 0.5% for parturient undergoing elective cesarean delivery
- 1 May 2005
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 22 (Supplement) , 102
Intrathecal S(+) ketamine, fentanyl, or placebo combined with bupivacaine 0.5% for parturient undergoing elective cesarean delivery
- 1 July 2004
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 48 (6) , 797
Remifentanil produces vasorelaxation in isolated rat thoracic aorta strips
- 1 July 2004
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 48 (6) , 797
Remifentanil produces vasorelaxation in isolated rat thoracic aorta strips
- 1 May 2003
- Published by Wolters Kluwer Health
- Vol. 20 (5) , 416-421
Postoperative pain management with intravenous patient-controlled morphine: comparison of the effect of adding magnesium or ketamine
This double-blind randomized study tested whether the addition of magnesium or ketamine to morphine for intravenous patient-controlled analgesia resulted in improved analgesic efficacy and lower pain scores compared with morphine patient-controlled analgesia alone after major abdominal surgery. Ninety patients (3 x 30) were randomly allocated to receive either morphine 0.4 mg mL(-1) (Group M) by patient-controlled analgesia, morphine 0.4mg mL(-1) + MgSO4 30mg mL(-1) (Group MM) or morphine 0.4 mg mL(-1) + ketamine 1 mg mL(-1) (Group MK). Postoperative analgesia was started when the verbal rating scale was > or = 2. Patients were first given a standardized loading dose (0.05 mg kg(-1)) of the study solution. They were then allowed to use bolus doses of this solution (0.0125 mg kg(-1) every 20 min without time limit). Discomfort, sedation, pain scores, cumulative morphine consumption and adverse effects were recorded up to 24 h after the start of the patient-controlled analgesia. The level of discomfort, level of sedation and verbal rating scores decreased significantly with time in all groups (P < 0.05). Both verbal rating and discomfort scores were significantly lower in Groups MM and MK at 15, 30 and 60 min compared with Group M (P < 0.001). Cumulative morphine consumption after 12 and 24 h was significantly higher in Group M alone (median 26 and 49 mg, respectively) compared with Group MM (24.2 and 45.7 mg) and Group MK (24.4 and 46.5 mg). In the immediate postoperative period, the addition of magnesium or ketamine to morphine for intravenous patient-controlled analgesia led to a significantly lower consumption of morphine. However, these differences are unlikely to be of any clinical relevance.
- 1 May 2003
- Published by Wolters Kluwer Health
- Vol. 20 (5) , 416-421
Postoperative pain management with intravenous patient-controlled morphine: comparison of the effect of adding magnesium or ketamine
This double-blind randomized study tested whether the addition of magnesium or ketamine to morphine for intravenous patient-controlled analgesia resulted in improved analgesic efficacy and lower pain scores compared with morphine patient-controlled analgesia alone after major abdominal surgery. Ninety patients (3 x 30) were randomly allocated to receive either morphine 0.4 mg mL(-1) (Group M) by patient-controlled analgesia, morphine 0.4mg mL(-1) + MgSO4 30mg mL(-1) (Group MM) or morphine 0.4 mg mL(-1) + ketamine 1 mg mL(-1) (Group MK). Postoperative analgesia was started when the verbal rating scale was > or = 2. Patients were first given a standardized loading dose (0.05 mg kg(-1)) of the study solution. They were then allowed to use bolus doses of this solution (0.0125 mg kg(-1) every 20 min without time limit). Discomfort, sedation, pain scores, cumulative morphine consumption and adverse effects were recorded up to 24 h after the start of the patient-controlled analgesia. The level of discomfort, level of sedation and verbal rating scores decreased significantly with time in all groups (P < 0.05). Both verbal rating and discomfort scores were significantly lower in Groups MM and MK at 15, 30 and 60 min compared with Group M (P < 0.001). Cumulative morphine consumption after 12 and 24 h was significantly higher in Group M alone (median 26 and 49 mg, respectively) compared with Group MM (24.2 and 45.7 mg) and Group MK (24.4 and 46.5 mg). In the immediate postoperative period, the addition of magnesium or ketamine to morphine for intravenous patient-controlled analgesia led to a significantly lower consumption of morphine. However, these differences are unlikely to be of any clinical relevance.
- 1 January 1999
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 21 (3) , 238-239
A reply
- 1 January 1999
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 21 (3) , 238-239
A reply